https://www.openbell.ai/ 2026-10-13T10:38:18.053Z hourly 1.0 https://www.openbell.ai/support 2026-10-13T10:38:18.053Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-13T10:38:18.053Z monthly 0.5 https://www.openbell.ai/terms 2026-10-13T10:38:18.053Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-13T10:38:18.053Z hourly 0.8 https://www.openbell.ai/news/AVGO:1791887823491 2026-10-13T10:37:03.491Z daily 0.9 https://cdn.brandfetch.io/AVGO/w/400/h/400?c=1idopYfmtR7ZKg8QMud AI Stock Crash Could Trigger Global Market Turmoil, Warns IMF, as Debt and Cyber Risks Mount: 'Resilience Is Not Safety' The International Monetary Fund (IMF) has warned that a significant decline in AI stock valuations could lead to global market instability, exacerbated by high government borrowing costs and potential cyber threats. The IMF's Global Financial Stability Report highlights that a selloff in AI investments could particularly impact Asian markets, while U.S. asset holders may also face losses. The report emphasizes that while global markets have shown resilience, existing vulnerabilities could amplify risks, with corporate debt and retail borrowing potentially increasing market volatility. https://www.openbell.ai/news/INCY:1791887818160 2026-10-13T10:36:58.160Z daily 0.9 https://cdn.brandfetch.io/INCY/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $152 Price Target HC Wainwright & Co. analyst Mitchell S. Kapoor has reiterated a Buy rating on Incyte (NASDAQ: INCY) and maintained a price target of $152 for the stock. https://www.openbell.ai/news/ASTS:1791887786324 2026-10-13T10:36:26.324Z daily 0.9 https://cdn.brandfetch.io/ASTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Downgrades AST SpaceMobile to Neutral, Lowers Price Target to $54 Piper Sandler analyst Alexander Potter has downgraded AST SpaceMobile (NASDAQ: ASTS) from Overweight to Neutral. The price target has been reduced significantly from $98 to $54. https://www.openbell.ai/news/CDNL:1791887785479 2026-10-13T10:36:25.479Z daily 0.9 https://cdn.brandfetch.io/CDNL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cardinal Infrastructure Group Agrees To Acquire Hughes Brothers Construction For $357.5M Cardinal Infrastructure Group, Inc. (NASDAQ: CDNL) has announced its agreement to acquire Hughes Brothers Construction, Inc. for $357.5 million, with the transaction expected to close in Q4 2026, pending regulatory approvals. The acquisition is projected to be immediately accretive to Cardinal's 2026 adjusted EBITDA margin, with Hughes Brothers reporting trailing 12-month revenue of over $220 million and a backlog of approximately $350 million. The deal will be financed through cash and Cardinal Class A common stock, with potential additional payments of up to $97.5 million based on future performance, bringing the total potential transaction value to around $455 million. https://www.openbell.ai/news/ITRG:1791887689782 2026-10-13T10:34:49.782Z daily 0.9 https://cdn.brandfetch.io/ITRG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Integra Advances DeLamar Development Ahead Of Final Investment Decision Integra Resources Corp. is advancing its DeLamar Gold-Silver Project in Idaho, following the completion of the Feasibility Study in December 2025. The company is focusing on detailed engineering, procurement, site infrastructure, permitting, and project financing to enhance project readiness before a Final Investment Decision (FID), expected after the Environmental Impact Statement and Record of Decision are published in the second half of 2027. https://www.openbell.ai/news/EQX:1791887643894 2026-10-13T10:34:03.894Z daily 0.9 https://cdn.brandfetch.io/EQX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Equinox Gold Reports Q3 Gold Production Of 237,019 Oz., Gold Sales Of 248,484 Oz.; Consolidated YtD Gold Production Of 611,483 Oz.; Company Remains On Track To Achieve Updated 2026 Gold Production Guidance Equinox Gold reported third-quarter gold production of 237,019 ounces and gold sales of 248,484 ounces, with a consolidated year-to-date production of 611,483 ounces. The company is on track to meet its updated 2026 gold production guidance of 870,000 to 920,000 ounces. During the quarter, Equinox repaid $190 million in debt, bringing total debt repayments to approximately $1.2 billion year-to-date, and ended the quarter with $527 million in cash. Additionally, the company repurchased 759,000 shares for about $9 million, continuing its share repurchase program. https://www.openbell.ai/news/ZBIO:1791887642381 2026-10-13T10:34:02.381Z daily 0.9 https://cdn.brandfetch.io/ZBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Zenas BioPharma, Maintains $44 Price Target HC Wainwright & Co. analyst Matthew Caufield has reiterated a Buy rating on Zenas BioPharma (NASDAQ: ZBIO) and maintained a price target of $44 for the stock. https://www.openbell.ai/news/BJDX:1791887629647 2026-10-13T10:33:49.647Z daily 0.9 https://cdn.brandfetch.io/BJDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bluejay Diagnostics Completes Establishment Of Manufacturing Site For Symphony Cartridges, Reaching Contractual Milestone As It Advances Toward Regulatory Submission And Potential Commercialization Bluejay Diagnostics, Inc. (NASDAQ: BJDX) has completed the establishment of a manufacturing site for its Symphony™ cartridges, marking a significant contractual milestone with Toray. This development is a step forward as the company prepares for regulatory submission and potential commercialization of its near-patient diagnostic platform. https://www.openbell.ai/news/GMAB:1791887380631 2026-10-13T10:29:40.631Z daily 0.9 https://cdn.brandfetch.io/GMAB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Genmab Reports Q3 DARZALEX Net Sales Of $4.239B Genmab reported that worldwide net trade sales of DARZALEX reached $4.239 billion in Q3 2026, with $2.528 billion from the U.S. and $1.711 billion from international markets. The company earns royalties on these sales under its exclusive license agreement with Johnson & Johnson for the development and commercialization of daratumumab. https://www.openbell.ai/news/UNH:1791887298016 2026-10-13T10:28:18.016Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Top-Trades-Yield-Big-Gains.jpg?width=250&height=187 Why UnitedHealth Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket UnitedHealth Group Incorporated (NYSE: UNH) shares increased by 2.6% to $387.52 in pre-market trading following the release of strong third-quarter results. The company reported earnings of $4.69 per share, surpassing the analyst consensus estimate of $4.15, and quarterly sales of $112.694 billion, exceeding the expected $111.403 billion. https://www.openbell.ai/news/MDB:1791887227422 2026-10-13T10:27:07.422Z daily 0.9 https://cdn.brandfetch.io/MDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Reiterates Buy on MongoDB, Maintains $430 Price Target Needham analyst Mike Cikos has reiterated a Buy rating on MongoDB (NASDAQ: MDB) and has maintained a price target of $430 for the stock. https://www.openbell.ai/news/BDSX:1791887167446 2026-10-13T10:26:07.446Z daily 0.9 https://cdn.brandfetch.io/BDSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Biodesix Announces Multiple Presentations At CHEST 2026 Highlighting How Nodify Lung Testing Is Being Incorporated Into Real-World Lung Nodule Management Biodesix presented multiple studies at CHEST 2026, focusing on the integration of Nodify Lung testing in lung nodule management. The CLARIFY study, which has enrolled over 2,000 patients, highlights the effectiveness of blood-based lung nodule risk assessment in clinical decision-making and patient follow-up adherence. Key presentations include analyses comparing Nodify Lung testing with PET imaging, showcasing its growing clinical adoption and value in structured care pathways. https://www.openbell.ai/news/ACN:1791887072021 2026-10-13T10:24:32.021Z daily 0.9 https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Accenture Acquires UK Data And Customer Intelligence Firm Sagacity; Terms Not Disclosed Accenture has acquired UK-based data and customer intelligence firm Sagacity to enhance its capabilities in connecting data, AI, and operations. Founded in 2005, Sagacity brings valuable data assets and expertise that will complement Accenture's offerings, particularly in industries with complex customer journeys such as utilities and retail. This acquisition adds over 140 professionals to Accenture Song's UK and Ireland operations, aiming to accelerate the transition from customer insight to actionable strategies. Financial terms of the deal were not disclosed. https://www.openbell.ai/news/REXR:1791887060803 2026-10-13T10:24:20.803Z daily 0.9 https://cdn.brandfetch.io/REXR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mizuho Upgrades Rexford Industrial Realty to Outperform, Raises Price Target to $41 Mizuho analyst Vikram Malhotra has upgraded Rexford Industrial Realty (NYSE: REXR) from Neutral to Outperform. The price target for the stock has been increased from $38 to $41. https://www.openbell.ai/news/NRIX:1791887048760 2026-10-13T10:24:08.760Z daily 0.9 https://cdn.brandfetch.io/NRIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Reiterates Buy on Nurix Therapeutics, Maintains $34 Price Target Needham analyst Gil Blum has reiterated a Buy rating on Nurix Therapeutics (NASDAQ: NRIX) and maintained a price target of $34 for the stock. No specific financial figures or market impacts were mentioned in the article. https://www.openbell.ai/news/SSRM:1791887005797 2026-10-13T10:23:25.797Z daily 0.9 https://cdn.brandfetch.io/SSRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud SSR Mining To Acquire Roxmore Resources For C$6.75/Share In Cash Plus Shares Of New SpinCo To Hold Interests In Roxmore’s Rattlesnake Hills Project, Shabu River Project, And Newton Property SSR Mining has announced its acquisition of Roxmore Resources for C$6.75 per share in cash, along with shares in a newly created company, SpinCo, which will hold interests in Roxmore's Rattlesnake Hills, Shabu River, and Newton projects. The cash offer represents a 27% premium over Roxmore's closing price on October 9, 2026, and the total equity value of the transaction is estimated at approximately $464 million. The acquisition is expected to create over $200 million in life-of-mine synergies and enhance SSR Mining's production capabilities, with potential annual gold production of 150,000 to 170,000 ounces from the Converse project starting in 2033. https://www.openbell.ai/news/CRM:1791886949621 2026-10-13T10:22:29.621Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Salesforce.jpg?width=250&height=187 Salesforce Buys AI Startup That Tells Businesses What's Going Wrong Salesforce Inc. has signed a definitive agreement to acquire AI startup Loops for approximately $30 million, aiming to enhance Tableau's AI capabilities. The acquisition is expected to close in early November 2023 and will integrate Loops' technology into Salesforce's analytics platform. Additionally, Bank of America upgraded Salesforce's stock rating from Underperform to Buy, raising its price forecast from $160 to $285, citing strong AI growth prospects and a significant increase in Agentforce's annual recurring revenue, which reached $1.5 billion in Q2 of fiscal 2027. https://www.openbell.ai/news/JNJ:1791886924075 2026-10-13T10:22:04.075Z daily 0.9 https://cdn.brandfetch.io/JNJ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Johnson & Johnson Raises FY2026 Adj EPS Guidance from $10.96-$11.11 to $11.05-$11.15 vs $11.08 Est; Raises FY2026 Sales Guidance from $100.800B-$101.400B to $101.000B-$101.400B vs $101.296B Est Johnson & Johnson has increased its FY2026 adjusted EPS guidance from a range of $10.96-$11.11 to $11.05-$11.15, compared to an analyst estimate of $11.08. Additionally, the company raised its FY2026 sales outlook from $100.800 billion-$101.400 billion to $101.000 billion-$101.400 billion, against an estimate of $101.296 billion. https://www.openbell.ai/news/ACGL:1791886918017 2026-10-13T10:21:58.017Z daily 0.9 https://cdn.brandfetch.io/ACGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Downgrades Arch Capital Group to Equal-Weight, Lowers Price Target to $100 Morgan Stanley analyst Bob Huang has downgraded Arch Capital Group (NASDAQ: ACGL) from Overweight to Equal-Weight. The price target for the stock has been reduced from $105 to $100. https://www.openbell.ai/news/JNJ:1791886843809 2026-10-13T10:20:43.809Z daily 0.9 https://cdn.brandfetch.io/JNJ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Johnson & Johnson Q3 Adj. EPS $2.59 Beats $2.53 Estimate, Sales $25.399B Beat $25.251B Estimate openbell Financial News https://www.openbell.ai/news/SSRM:1791886798854 2026-10-13T10:19:58.854Z daily 0.9 https://cdn.brandfetch.io/SSRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud SSR Mining Announces Results Of Technical Report Summary For Marigold Gold Complex In Nevada; Sees NPV5% Of $3.3B And $3.8B At Consensus And Spot Prices, Respectively SSR Mining announced the results of its technical report for the Marigold Gold Complex in Nevada, projecting an after-tax NPV5% of $3.3 billion at consensus gold prices. The report anticipates average annual gold production of 231,000 ounces from 2027 to 2031, with total gold Mineral Reserves increasing by 43% to 4.6 million ounces. Additionally, the company plans a growth capital investment of $542 million to support mining operations and the development of the Buffalo Valley project, which is expected to produce its first gold in 2029. https://www.openbell.ai/news/SYM:1791886629903 2026-10-13T10:17:09.903Z daily 0.9 https://cdn.brandfetch.io/SYM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Symbotic Acquires German Automation Company Cellumation; Financial Terms Not Disclosed Symbotic has acquired the German automation company cellumation, known for its patented celluveyor sortation technology, although financial terms of the deal were not disclosed. This acquisition is expected to enhance Symbotic's capabilities in warehouse automation by increasing throughput and optimizing space utilization. Cellumation will continue to operate under its own name while integrating its technology into Symbotic's systems, further expanding Symbotic's presence in Europe and supporting its strategic roadmap. The leadership team of cellumation will remain in place to continue operations. https://www.openbell.ai/news/BAC:1791886514676 2026-10-13T10:15:14.676Z daily 0.9 https://cdn.brandfetch.io/BAC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bank Of America Tells Bankers It Intends To Climb League Tables, Seeks To Hire Senior Bankers; Reassures Bankers Following String Of Top Investment-Bank Departures; Bank Is Hiring Senior Bankers With Focus On Technology - Reuters Exclusive Bank of America has announced its intention to improve its position in investment banking league tables and is actively seeking to hire senior bankers, particularly with expertise in technology. This move comes in response to recent departures of top investment bankers from the firm. The bank aims to reassure its remaining staff about its ambitions and commitment to growth in the sector. https://www.openbell.ai/news/CYRX:1791886414344 2026-10-13T10:13:34.344Z daily 0.9 https://cdn.brandfetch.io/CYRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Maintains Buy on CryoPort, Raises Price Target to $26 BTIG analyst David Larsen has maintained a 'Buy' rating on CryoPort (NASDAQ: CYRX) and raised the price target from $25 to $26. This adjustment reflects the analyst's positive outlook on the company's performance. https://www.openbell.ai/news/BEEM:1791886390689 2026-10-13T10:13:10.689Z daily 0.9 https://cdn.brandfetch.io/BEEM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Beam Global Reports Preliminary Q3 Sales Of ~$6.2M, Up 8% YoY Beam Global reported preliminary Q3 sales of approximately $6.2 million, reflecting an 8% year-over-year increase. The company is preparing to expand into the drone technology market through its pending acquisition of ScoutDI for around $24 million in cash and stock, which is expected to close in November 2026. This acquisition aims to enhance Beam Global's capabilities in serving commercial, government, and defense markets with advanced drone technology. https://www.openbell.ai/news/UNTY:1791886390243 2026-10-13T10:13:10.243Z daily 0.9 https://cdn.brandfetch.io/UNTY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Unity Bancorp Q3 EPS $1.70 Beats $1.55 Estimate, Sales $36.650M Beat $35.663M Estimate Unity Bancorp (NASDAQ: UNTY) reported Q3 earnings of $1.70 per share, surpassing the analyst estimate of $1.55 by 9.68%, and marking a 27.82% increase from $1.33 per share in the same quarter last year. The company's quarterly sales reached $36.650 million, exceeding the expected $35.663 million by 2.77%, and reflecting an 11.66% growth compared to $32.823 million in the prior year. https://www.openbell.ai/news/S:1791886315538 2026-10-13T10:11:55.538Z daily 0.9 https://cdn.brandfetch.io/S/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Maintains Buy on SentinelOne, Raises Price Target to $31 Needham analyst Mike Cikos has maintained a 'Buy' rating on SentinelOne (NYSE: S) and increased the price target from $26 to $31. https://www.openbell.ai/news/HUM:1791886291413 2026-10-13T10:11:31.413Z daily 0.9 https://cdn.brandfetch.io/HUM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Humana Forms JV With BlackRock To Manage And Operate Existing Network Of CenterWell Senior Primary Care Clinics; Reaffirms FY26 Adjusted EPS Guidance Humana Inc. has entered a joint venture with BlackRock to manage its CenterWell Senior Primary Care clinics, replacing existing partnerships with Welsh, Carson, Anderson & Stowe. This new arrangement is expected to significantly reduce Humana's balance sheet liabilities and lower its cost of capital. Additionally, Humana reaffirmed its FY 2026 adjusted earnings per share guidance of at least $9.00, while noting potential changes to its GAAP EPS guidance due to ongoing strategic initiatives. https://www.openbell.ai/news/SNDK:1791886249882 2026-10-13T10:10:49.882Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Sandisk.jpg?width=250&height=187 Why Is Sandisk Stock Falling Tuesday? Sandisk Corp. (NASDAQ: SNDK) saw its stock decline nearly 4% on Tuesday, following a significant selloff that erased about $15 billion in market value on Monday. The drop is attributed to rising competition from Chinese suppliers, particularly ChangXin Memory Technologies, and softer flash-memory pricing, impacting the broader semiconductor sector. Despite the recent downturn, Sandisk's stock remains up approximately 530% in 2026, with earnings scheduled to be reported on October 29, 2026, where analysts expect EPS of $46.22 and revenue of $10.64 billion. https://www.openbell.ai/news/SNDK:1791886206456 2026-10-13T10:10:06.456Z daily 0.9 https://cdn.brandfetch.io/SNDK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Sandisk Stock Falling Tuesday? Sandisk Corp. (NASDAQ: SNDK) saw its stock fall nearly 4% on Tuesday, following a significant selloff that erased about $15 billion in market value on Monday. The decline is attributed to rising competition from Chinese manufacturers, particularly ChangXin Memory Technologies, and softer pricing in the flash-memory market, which has affected the broader semiconductor sector. Despite this, Sandisk's stock remains up approximately 530% in 2026, and analysts expect strong earnings on October 29, 2026, with projected EPS of $46.22 and revenue of $10.64 billion. https://www.openbell.ai/news/CGTX:1791886125547 2026-10-13T10:08:45.547Z daily 0.9 https://cdn.brandfetch.io/CGTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cognition Therapeutics Receives U.S. Patent Covering A Polymorph Version Of Its Lead Drug Candidate Zervimesine Cognition Therapeutics has been granted U.S. Patent No. 12,759,979 for a polymorph version of its lead drug candidate, zervimesine, which is set to expire in 2045, with potential for a five-year extension upon FDA approval. The patent covers the composition of matter, production process, and therapeutic methods for treating age-related degenerative disorders, including Alzheimer's disease and dry age-related macular degeneration. https://www.openbell.ai/news/HESM:1791886083902 2026-10-13T10:08:03.902Z daily 0.9 https://cdn.brandfetch.io/HESM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Underweight on Hess Midstream, Lowers Price Target to $30 Morgan Stanley analyst Robert Kad has maintained an Underweight rating on Hess Midstream (NYSE: HESM) and has reduced the price target from $39 to $30. https://www.openbell.ai/news/IMRN:1791885993324 2026-10-13T10:06:33.324Z daily 0.9 https://cdn.brandfetch.io/IMRN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Immuron Announces Publication Of Data From Its Phase 2 Clinical Trial Of Once-Daily Oral Travelan In 'Scientific Reports'; Statistically Significant 50% Reduction In ETEC Challenge-Related Adverse Events Versus Placebo Immuron Limited (ASX: IMC, NASDAQ: IMRN) announced the publication of data from its Phase 2 clinical trial of Travelan in the journal Scientific Reports, highlighting a statistically significant 50% reduction in ETEC challenge-related adverse events compared to placebo (P=0.0001). The study, partially funded by the U.S. Department of Defense, showed a 40% reduction in moderate-to-severe diarrhea and a 71% reduction in early antibiotic use among Travelan recipients. Despite not meeting its primary efficacy endpoints due to a lower than anticipated placebo attack rate, the findings support the potential protective benefits of Travelan against ETEC-associated disease. Immuron is advancing Travelan as a non-antibiotic oral immunoprophylactic for gastrointestinal health. https://www.openbell.ai/news/JPM:1791885977036 2026-10-13T10:06:17.036Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/JPMorgan-Chase--Co.jpg?width=250&height=187 Institutional Confidence in Banks Has Collapsed Ahead of Earnings The banking sector has seen a significant decline, with the five largest U.S. banks losing approximately $270 billion from their summer peaks, while the broader market has risen about 14% this year. A Truist Securities survey indicates that only 35% of institutional investors expect banks to outperform the market, a sharp drop from 82% in December 2025. Earnings season is beginning, with major banks like JPMorgan Chase, Goldman Sachs, Wells Fargo, and Citigroup set to report, amidst pressures on net interest margins due to rising funding costs and a challenging interest rate environment. https://www.openbell.ai/news/DPZ:1791885974077 2026-10-13T10:06:14.077Z daily 0.9 https://cdn.brandfetch.io/DPZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Domino's Pizza Q3 EPS $4.60 Beats $4.36 Estimate, Sales $1.186B Beat $1.177B Estimate Domino's Pizza (NASDAQ: DPZ) reported Q3 earnings of $4.60 per share, exceeding the analyst estimate of $4.36 by 5.5%, and marking a 12.75% increase from $4.08 per share in the same quarter last year. The company's sales reached $1.186 billion, surpassing the expected $1.177 billion by 0.81%, and reflecting a 3.40% growth compared to $1.147 billion in the previous year. https://www.openbell.ai/news/TSEM:1791885882324 2026-10-13T10:04:42.324Z daily 0.9 https://cdn.brandfetch.io/TSEM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tower Semiconductor And Semtech Expand Multi-Year Agreement With SMTC Investing Dedicated Silicon Germanium Capacity At Tower Tower Semiconductor and Semtech Corporation have expanded their multi-year agreement, which builds on a 20-year partnership. Semtech will invest in dedicated silicon germanium (SiGe) capacity at Tower to support increasing demand for AI data center optical interconnect components. This agreement enhances supply resilience and geographic diversification for Semtech's manufacturing strategy, as demand for SiGe-based products is anticipated to grow across various customer programs and markets. https://www.openbell.ai/news/MIRM:1791885878998 2026-10-13T10:04:38.998Z daily 0.9 https://cdn.brandfetch.io/MIRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Mirum Pharmaceuticals, Raises Price Target to $152 Morgan Stanley analyst Michael Ulz has maintained an Overweight rating on Mirum Pharmaceuticals (NASDAQ: MIRM) and raised the price target from $137 to $152. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/BTCUSD:1791885826573 2026-10-13T10:03:46.573Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Cryptocurrency--Focus-Bitcoin-On-Tablet-.jpg?width=250&height=187 Russia's Largest Exchange Sets Date for Crypto Trading Launch as BTC, ETH and USDT Move Into Regulated Market The Moscow Exchange (MOEX), Russia's largest exchange, is set to launch cryptocurrency trading in December, marking a significant step towards integrating digital assets into the country's financial infrastructure. The exchange has begun testing operations with professional market participants and will allow retail investors to trade Bitcoin, Ethereum, and Tether, with a limit of 300,000 rubles ($3,582.28). This initiative follows the implementation of a new law on digital currencies in September, which provides a legal framework for cryptocurrency transactions. https://www.openbell.ai/news/WTFC:1791885665117 2026-10-13T10:01:05.117Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Other-Analysts-Turn-Bullish.jpg?width=250&height=187 Wintrust Financial Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Wintrust Financial Corporation (NASDAQ: WTFC) is set to release its Q3 earnings on October 19, with analysts forecasting earnings of $3.31 per share, an increase from $3.06 per share in the prior year, and expected revenue of $754.79 million, up from $697.84 million last year. Following a better-than-expected second-quarter report, shares rose 0.7% to close at $144.20. Recent analyst ratings include Barclays maintaining an Overweight rating with a price target cut from $192 to $190, and Piper Sandler increasing its price target from $186 to $195 while also maintaining an Overweight rating. https://www.openbell.ai/news/XLE:1791885406021 2026-10-13T09:56:46.021Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/The-Word-War-With-The-Iranian-And-Americ.jpg?width=250&height=187 Charlie Bilello Says Iran War Inflation Is 'Rewarding Big Oil,' Flags a 56% Spread Between XLE and XLY Charlie Bilello, Chief Market Strategist at Creative Planning, highlighted a significant 56% performance gap between the S&P 500's energy sector (XLE) and consumer discretionary sector (XLY), with XLE up over 50% year-to-date while XLY has declined by 5.4%. He noted that war-driven inflation is benefiting energy stocks but negatively impacting consumers, as prices for various commodities have surged significantly since the onset of the Iran conflict. For instance, European natural gas prices have increased by 163%, and gasoline prices are up 46%, with the national average now at $4.34 per gallon. https://www.openbell.ai/news/UNH:1791885394442 2026-10-13T09:56:34.442Z daily 0.9 https://cdn.brandfetch.io/UNH/w/400/h/400?c=1idopYfmtR7ZKg8QMud UnitedHealth Group FY2026 GAAP EPS expected to be more than $19.50 vs $18.35 Est UnitedHealth Group (NYSE: UNH) is projected to report a GAAP EPS of more than $19.50 for FY2026, exceeding the previous estimate of $18.35. This indicates a positive outlook for the company's financial performance in the coming years. https://www.openbell.ai/news/UNH:1791885384594 2026-10-13T09:56:24.594Z daily 0.9 https://cdn.brandfetch.io/UNH/w/400/h/400?c=1idopYfmtR7ZKg8QMud UnitedHealth Group FY2026 Adj EPS expected to be more than $20.50 vs $19.86 Est UnitedHealth Group (NYSE: UNH) has projected its adjusted earnings per share (EPS) for FY2026 to exceed $20.50, surpassing the previous estimate of $19.86. This indicates a positive outlook for the company's financial performance in the upcoming fiscal year. https://www.openbell.ai/news/UNH:1791885330121 2026-10-13T09:55:30.121Z daily 0.9 https://cdn.brandfetch.io/UNH/w/400/h/400?c=1idopYfmtR7ZKg8QMud UnitedHealth Group Q3 Adj. EPS $4.69 Beats $4.15 Estimate, Sales $112.694B Beat $111.403B Estimate UnitedHealth Group reported Q3 adjusted earnings per share of $4.69, exceeding the analyst estimate of $4.15 by 13.01%, and marking a 60.62% increase from $2.92 per share in the same quarter last year. The company's sales reached $112.694 billion, surpassing the expected $111.403 billion by 1.16%, although this reflects a 0.41% decline from $113.161 billion in Q3 of the previous year. https://www.openbell.ai/news/V:1791885241993 2026-10-13T09:54:01.993Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Visa-Inc.jpg?width=250&height=187 Visa Eyes China's Vast Payments Market After Key Regulatory Breakthrough Visa Inc. received regulatory approval from the People's Bank of China to prepare for a domestic bankcard clearing institution, marking a significant step towards entering China's payments market. Following this news, Visa's stock rose 1.47% to $395 in premarket trading. The company is set to report its fiscal fourth-quarter results on October 27, with analysts expecting earnings of $3.43 per share and revenue of $12.07 billion. Visa's stock carries a Buy consensus rating, with price forecasts raised by several analysts, including Baird to $430 and RBC Capital Markets to $466. https://www.openbell.ai/news/AVGO:1791884064897 2026-10-13T09:34:24.897Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Broadcom.jpg?width=250&height=187 What's Going On With Broadcom Stock Tuesday? Broadcom Inc. (NASDAQ: AVGO) stock is down 0.75% to $352.07 in premarket trading, influenced by a 0.39% decline in Nasdaq futures. The company has launched VMware HyperArmor, a new security solution aimed at enhancing protection against cyberattacks on VMware Cloud Foundation. Despite trading below its key moving averages, Broadcom holds a Buy consensus rating with an average price target of $518.72 from analysts, although its financial quality is strong, it faces challenges due to a premium valuation. https://www.openbell.ai/news/VFC:1791883138404 2026-10-13T09:18:58.404Z daily 0.9 https://cdn.brandfetch.io/VFC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Upgrades VF to Overweight, Raises Price Target to $20 Piper Sandler analyst Anna Andreeva has upgraded VF (NYSE: VFC) from Neutral to Overweight. Additionally, the price target for the stock has been raised from $16 to $20. https://www.openbell.ai/news/OIG:1791882490951 2026-10-13T09:08:10.951Z daily 0.9 https://cdn.brandfetch.io/OIG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Initiates Coverage On Orion180 Insurance Gr with Buy Rating, Announces Price Target of $13 Goldman Sachs analyst Robert Cox has initiated coverage on Orion180 Insurance Group (NASDAQ: OIG) with a Buy rating. The firm has set a price target of $13 for the stock. https://www.openbell.ai/news/MU:1791882477876 2026-10-13T09:07:57.876Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud China’s CXMT On Monday Reported Major Progress On Proprietary Memory Chip Transistor Structure Also Pursued By Samsung, SK Hynix, Aiming To Increase Storage Density And Improve Efficiency China's CXMT announced significant advancements in its proprietary memory chip transistor structure, which is also being pursued by major competitors Samsung and SK Hynix. This development aims to enhance storage density and improve efficiency in memory chips. The progress could impact the competitive landscape in the semiconductor industry, particularly affecting companies like Micron Technology (MU). https://www.openbell.ai/news/META:1791881808226 2026-10-13T08:56:48.226Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Mark-Zuckerberg-Speaks-At-Georgetown-Uni.jpg?width=250&height=187 Mark Zuckerberg Defends Meta's AI CapEx, Ready to 'Write This Check' for up to '$200 Billion' to Dominate 'Decades to Come' Meta Platforms Inc. CEO Mark Zuckerberg announced the company's readiness to invest between $100 billion and $200 billion in AI initiatives, including the development of high-capacity computing facilities like the 'Prometheus' cluster in Ohio and the 'Hyperion' cluster in Louisiana. Zuckerberg emphasized that these investments are supported by Meta's profitable core business and strong credit, positioning the company for long-term leadership in AI. The stock closed at $742.96, reflecting a year-to-date increase of 12.55%. https://www.openbell.ai/news/SNDK:1791880097282 2026-10-13T08:28:17.282Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Milpitas--Ca---Feb--12--2017-Sandisk---A.jpg?width=250&height=187 EXCLUSIVE: SanDisk Has ‘More Upside,’ Says Nicholas Mugalli — His $3,000 Target Implies a 102% Rally for SNDK SanDisk Corp. (NASDAQ: SNDK) is projected to reach a price target of $3,000, implying a 102% upside, according to Nicholas Mugalli, CEO of World Trade Securities. This valuation is based on Mizuho's FY2030 revenue estimate of over $80 billion and an expected earnings per share (EPS) of approximately $330. Analysts maintain a Buy consensus on SanDisk, with an average price target of $1,651, while the stock closed at $1,487.33, reflecting a 5.97% decline on the last trading day.